bioAffinity Technologies Inc.
5 clinical trials · Sponsor
◉ Watch bioAffinity Technologies Inc.
| Record | Firm | Date |
|---|---|---|
| Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT. (NCT07168993) | bioAffinity Technologies Inc. | 2026-02-25 |
| Collection of Sputum and Labeling for Lung Cancer (NCT03457415) | bioAffinity Technologies Inc. | 2018-03-01 |
Track bioAffinity Technologies Inc. automatically
Every clearance here is in the API, with alerts when new ones post.